Stella Diagnostics, Inc. (SLDX)
OTCMKTS · Delayed Price · Currency is USD
0.0490
+0.0090 (22.50%)
At close: Apr 4, 2025

Stella Diagnostics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 2008
Period Ending
Dec '13 Dec '12 Dec '11 Dec '10 Dec '09 2008
Net Income
-0.26-0.77-0.28-1.14-0.52
Upgrade
Depreciation & Amortization
-0.050.050.060.09
Upgrade
Change in Accounts Receivable
-0.05--00.01-0.06
Upgrade
Change in Inventory
----0.03-
Upgrade
Change in Accounts Payable
0.020.010.53-0.320.47
Upgrade
Change in Other Net Operating Assets
0.290.39-0.812.040.26
Upgrade
Operating Cash Flow
0-0.33-0.520.620.25
Upgrade
Operating Cash Flow Growth
---152.87%2.45%
Upgrade
Capital Expenditures
----0.63-0.31
Upgrade
Sale of Property, Plant & Equipment
--0.13--
Upgrade
Other Investing Activities
-0.03----
Upgrade
Investing Cash Flow
-0.03-0.13-0.63-0.31
Upgrade
Long-Term Debt Issued
-0.33---
Upgrade
Net Debt Issued (Repaid)
-0.33---
Upgrade
Issuance of Common Stock
--0.1--
Upgrade
Financing Cash Flow
-0.330.39-0.07
Upgrade
Miscellaneous Cash Flow Adjustments
0.03----
Upgrade
Net Cash Flow
0--0-0.010.01
Upgrade
Free Cash Flow
0-0.33-0.52-0.01-0.07
Upgrade
Free Cash Flow Margin
---11550.67%-2.44%-32.87%
Upgrade
Free Cash Flow Per Share
0.01----
Upgrade
Levered Free Cash Flow
-0.14-0.810-2.11-0.08
Upgrade
Unlevered Free Cash Flow
-0.14-0.810-2.11-0.08
Upgrade
Change in Net Working Capital
-0.030.51-0.590.84-0.48
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.